Atea Pharmaceuticals, Inc. (AVIR)

NASDAQ: AVIR · IEX Real-Time Price · USD

3.570

-0.110 (-2.99%)

At close: Jul 19, 2024, 4:00 PM

3.650

+0.080 (2.24%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Atea Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Revenue	0	0	0	351.37	48.63	0	Upgrade
Revenue Growth (YoY)	-	-	-	622.49%	-	-	Upgrade
Gross Profit	0	0	0	351.37	48.63	0	Upgrade
Selling, General & Admin	49.54	49.92	48.71	45.79	21.64	4.44	Upgrade
Research & Development	142.86	114.24	81.94	167.21	38.02	10.17	Upgrade
Operating Expenses	192.4	164.16	130.65	212.99	59.66	14.61	Upgrade
Operating Income	-192.4	-164.16	-130.65	138.38	-11.03	-14.61	Upgrade
Other Expense / Income	-29.79	-29.22	-11.15	-0.21	-0.08	-0.57	Upgrade
Pretax Income	-162.61	-134.94	-119.5	138.59	-10.95	-14.03	Upgrade
Income Tax	1.05	1.02	-3.59	17.4	0	0	Upgrade
Net Income	-163.66	-135.96	-115.91	121.19	-10.95	-14.03	Upgrade
Shares Outstanding (Basic)	84	83	83	83	22	10	Upgrade
Shares Outstanding (Diluted)	84	83	83	88	22	10	Upgrade
Shares Change	0.70%	0.17%	-5.67%	308.70%	113.98%	0.52%	Upgrade
EPS (Basic)	-1.96	-1.63	-1.39	1.46	-0.51	-1.39	Upgrade
EPS (Diluted)	-1.96	-1.63	-1.39	1.37	-0.51	-1.39	Upgrade
Free Cash Flow	-95.41	-85.4	-122.93	-87.01	296.71	-12.83	Upgrade
Free Cash Flow Per Share	-1.14	-1.02	-1.48	-1.05	13.74	-1.27	Upgrade
Gross Margin	-	-	-	100.00%	100.00%	-	Upgrade
Operating Margin	-	-	-	39.38%	-22.68%	-	Upgrade
Profit Margin	-	-	-	34.49%	-22.51%	-	Upgrade
Free Cash Flow Margin	-	-	-	-24.76%	610.10%	-	Upgrade
Effective Tax Rate	-	-	-	12.56%	-	-	Upgrade
EBITDA	-162.19	-134.52	-119.24	138.62	-10.93	-14.02	Upgrade
EBITDA Margin	-	-	-	39.45%	-22.47%	-	Upgrade
Depreciation & Amortization	0.42	0.42	0.26	0.03	0.02	0.02	Upgrade
EBIT	-162.61	-134.94	-119.5	138.59	-10.95	-14.03	Upgrade
EBIT Margin	-	-	-	39.44%	-22.51%	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).